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Antilope – A Lagrangian Relaxation Approach to
the de novo Peptide Sequencing Problem
Sandro Andreotti, Gunnar W. Klau∗, Knut Reinert∗
Abstract—Peptide sequencing from mass spectrometry data is
a key step in proteome research. Especially de novo sequencing,
the identification of a peptide from its spectrum alone, is still a
challenge even for state-of-the-art algorithmic approaches. In this
paper we present ANTILOPE, a new fast and flexible approach
based on mathematical programming. It builds on the spectrum
graph model and works with a variety of scoring schemes.
ANTILOPE combines Lagrangian relaxation for solving an integer
linear programming formulation with an adaptation of Yen’s
k shortest paths algorithm. It shows a significant improvement
in running time compared to mixed integer optimization and
performs at the same speed like other state-of-the-art tools. We
also implemented a generic probabilistic scoring scheme that
can be trained automatically for a dataset of annotated spectra
and is independent of the mass spectrometer type. Evaluations
on benchmark data show that ANTILOPE is competitive to the
popular state-of-the-art programs PepNovo and NovoHMM both
in terms of run time and accuracy. Furthermore, it offers
increased flexibility in the number of considered ion types.
ANTILOPE will be freely available as part of the open source
proteomics library OpenMS.
I. INTRODUCTION
Mass spectrometry-based high throughput identification of
peptides and proteins is a key step in most proteomics research
experiments. It requires fast algorithmic solutions with good
identification capabilities. Depending on the initial situation
of the experiment, two general strategies exist: database-
assisted and de novo identification. If a database for the
studied proteins exists the first method is usually preferred
over de novo sequencing. The crucial step in database search
algorithms like INSPECT [1], SEQUEST [2], Mascot [3]
and OMSSA [4] is to filter the database based on different
methods. INSPECT generates peptide sequence tags (PST)
and keeps only those candidate peptides containing the tag
as a subsequence. SEQUEST uses the parent mass as filter
criterion. After filtering, the query spectrum is scored against
the remaining candidates and a ranking of possible identifica-
tions is produced. In addition to the quality of the spectrum,
database search methods clearly depend on the correctness and
completeness of the database and hence on the availability of a
suitable set of peptides or transcripts for the studied organism.
Even if this is the case, factors like alternative splice variants
and mutations can lead to missing identifications.
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In such situations de novo sequencing algorithms provide an
alternative as they infer the sequence from the spectrum itself
without any information collected in databases. In recent years,
many algorithms and software packages were published, with
the most popular being PEAKS [5], PepNovo [6], NovoHMM
[7], Lutefisk [8], Sherenga [9], EigenMS [10], and PILOT [11].
Most of them use the graph-theoretical approach introduced
by Bartels [12] and construct a so-called N-C spectrum graph
which is then used to search for the correct sequence. See
Fig. 1.
Using this formulation, the de novo peptide sequencing
problem can be formulated as the search for the longest
antisymmetric path, an NP-complete problem [13]. PepNovo
and Lutefisk solve a special case of this problem by restricting
the construction of the spectrum graph, which enables them to
apply a dynamic programming algorithm proposed by Chen et
al. [14], [15]. The restrictions limit the possible interpretations
of each peak to at most one N-terminal (usually b-ion) and
one C-terminal (usually y-ion) ion type. Liu and Cai [16] use
tree-decomposition to solve the restricted problem. Bafna and
Edwards [17] propose a variant of the dynamic programming
approach that also allows for more interpretations leading to
a polynomial algorithm of a higher degree. Their algorithm is
still limited to so-called simple ion types, excluding doubly
and triply charged ions that can also aid the identification
process. PILOT [11] overcomes all these restrictions using an
integer linear programming (ILP) formulation for the longest
antisymmetric path problem that is flexible and extensible on
the cost of efficiency. This allows for more interpretations
of each peak which can lead to improved identification in
situations where the prominent b- and y-ions are missing.
Furthermore the ILP formulation can be easily extended in
several ways by simply adding or modifying constraints to
further restrict or modify the set of possible solutions. The
approach also allows for global reasoning such as limiting the
number of a certain amino acid type for each prediction.
The main contribution of this work is an improvement
of this approach by an extension that retains most of the
flexibility and leads to a remarkable improvement in running
time. Instead of focusing on computing one antisymmetric path
we propose a novel algorithm to find the k best antisymmetric
paths. We achieve this by applying the Lagrangian relaxation
technique to the problem and solving the subproblems with an
elegant variant of Yen’s k shortest paths algorithm. Lagrangian
relaxation was already successfully applied to biological prob-
lems such as sequence alignment [18], protein [19] and RNA
[20] structural alignment or protein threading [21].
An additional contribution of this paper is a generic prob-
abilistic scoring scheme that can be trained automatically
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Fig. 1. Spectrum graph generation. (a) Simplified tandem mass spectrum of the peptide VEALR. Rounded m/z values in Da are presented on top of each
peak. (b) The corresponding spectrum graph with two nodes being generated for each peak. One under the assumption of being a b-ion, the other under
the assumption of being a y-ion. It it obvious that the path starting at node s with mass 0 and ending at node t with mass 568 encodes the correct peptide
sequence. The undirected edges connecting complementary nodes are drawn as dashed lines.
for a dataset of annotated spectra and is independent of the
mass spectrometer type. The performance of both, de novo
and database search approaches, depends on a good scoring
function to model prediction quality. Currently used scor-
ing functions range from rather simple peak intensity-based
scoring to statistical models including Bayesian networks.
The latter show a better performance but require re-training
for different spectrometer types and thus depend on reliable
annotated datasets. Our flexible scoring scheme allows for
user controlled training on supplied annotated datasets. The
topology of the network can either be defined by the user
or, following the approach proposed by Bern [22], learned
from the given dataset directly. We extend this approach by
considering ion intensities and cleavage positions similar to
the PepNovo scoring in order to account for shifts of the
fragmentation patterns between different m/z regions along
the spectrum.
Our software ANTILOPE (ANTIsymmetric path search with
Lagrangian Optimization for PEptide identification), an imple-
mentation of the improved approach, is freely available as part
of upcoming releases of the open source proteomics library
OpenMS [23].
The structure of the remainder of this paper is as follows.
Section II describes our new method. In Section III we
compare our tool with the state-of-the-art tools PepNovo,
NovoHMM, LutefiskXP and PILOT. Finally, in Section IV,
we discuss our results and future work.
II. NOVEL DE NOVO PEPTIDE SEQUENCING ALGORITHM
This section describes our new approach to the de novo
sequencing problem. At first we formally introduce the graph-
theoretic formulation and the resulting ILP formulation our
method ANTILOPE is based on. Then we present our new
algorithmic approach to find the k best solutions of the ILP.
Finally, we explain the scoring model of ANTILOPE.
A. Graph-Theoretical Formulation
Bartels introduced the transformation of a tandem mass
spectrum into the so-called spectrum graph, a now commonly
used data structure in graph-theoretical approaches to the de
novo sequencing problem [6], [9], [16], see also Fig. 1. Using
this data structure, the original problem amounts to finding a
longest path with certain properties in this graph.
When a peptide P is fragmented by collision induced dis-
sociation (CID) it usually breaks along the backbone between
two neighboring amino acids into a pair of N-terminal (prefix)
and C-terminal (suffix) fragments. We define the residual
mass of P as the sum of the monoisotopic masses of all
amino acid residues in P . By parent mass MP we denote
the total mass of P , which is the residual mass, plus 18Da
for an additional water molecule. Depending on the exact
fragmentation position, different types of fragment ions are
produced that have a certain mass offset compared to the prefix
residue mass (PRM) or suffix residue mass. Besides the types
presented in Fig. 2, also neutral loss variants, e.g., loss of water
or ammonia, of several ion types are observed frequently as
well as multiply charged ions. The fragmentation process is
still not fully understood and which types are generated with
which intensity depends on many factors.
The spectrum graph G, consists of a set of nodes V , a set
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Fig. 2. Peptide fragmentation along the backbone. This figure displays the
most prominent fragmentation positions for the generation of pairs of b/y-ion,
a/x-ion and c/z-ion in the backbone of a peptide.
3of directed edges ED and a set of undirected edges EU . In
the original definition the spectrum graph does not contain the
set of undirected edges, which is a slight modification by Liu
and Cai [16] who termed this the extended spectrum graph. In
the spectrum graph each node corresponds to some possible
prefix residue mass of the peptide to be identified. Directed
edges represent amino acids and connect nodes if their mass
difference can be explained by some amino acid. Two nodes
that lead to contradicting interpretations of some mass peak
are called complementary and are connected by an undirected
edge.
Given the tandem mass spectrum of some unknown peptide
the construction of the spectrum graph is as follows: Each
peak s with mass ms in the input spectrum generates a set of
nodes. If we consider k different N-terminal ion types (e.g., b-
ion and a-ion) with mass offsets δ1, . . . , δk (+1Da for b-ions,
−27Da for a-ions) from the PRM, then peak s generates k
nodes with masses ms− δ1, . . . ,ms− δk. For C-terminal ion-
types with offsets δ1, . . . , δk, additional k nodes with masses
Mp−18− (ms−δ1), . . . ,Mp−18− (ms−δk) are generated.
Each of these nodes represents the prefix residue mass under
the assumption that s was generated by an ion of a certain
type. Clearly at most one of these nodes can represent the true
PRM, therefore they are all contradicting each other and are
connected by undirected edges. Whenever the mass difference
of two nodes vi and vk equals the mass of some amino acid α
(±ǫ), we connect vi and vk via a directed edge (vi, vk) labeled
with α. Finally we add two so called goalpost nodes s and t,
with masses 0 and PM − 18Da, respectively.
If the spectrum of some peptide P is complete, i.e., fragment
ion peaks are abundant for each possible cleavage site of P ,
then there exists a node for each PRM of P . Therefore the
correct sequence of P is obtained by finding the s-t-path of
nodes corresponding to the true prefix sequences of P and by
concatenation of the edge labels along this path. Each node in
the spectrum graph has a score that represents the reliability
of that node to correspond to a true PRM.
However, simply looking for the longest path in the graph
often leads to infeasible solutions, namely if two nodes that
were generated by the same peak are included in the path,
since in general only one of them corresponds to a true PRM.
This problem is aggravated when the score of each node is
directly related to the intensity of the generating peak. In
such a scenario a high intensity peak generates several high
scoring nodes and a longest path search then tends to include
a pair of complementary nodes in the longest path leading to
a contradicting N- and C-terminal interpretation of the same
peak. Such an infeasible path is called symmetric because the
pairs of forbidden pairs of N-terminal and C-terminal nodes
form a symmetric structure, which can be seen in Fig. 1. To
solve the de novo sequencing problem we hence have to search
for antisymmetric paths. These are paths without contradicting
nodes. They therefore do not contain pairs of nodes that are
connected by an undirected edge. See Fig. 3 for an example.
Most de novo sequencing algorithms generate one pair of
complementary nodes for each peak assuming it being either
a b-ion or y-ion. These pairs form a nested non-interleaving
structure allowing for efficient computation. But although b-
s t
Fig. 3. Symmetric path example. This figure sketches schematically the
situation when an infeasible symmetric path would be preferred over a feasible
antisymmetric solution. Assuming that the small nodes have a score of 1 and
the bold nodes have a score of 2, the illegal s-t path scores higher than the
legal one. Therefore, in this example, a simple longest path search yields
infeasible solutions.
and y-ions are usually the most abundant in CID spectra, there
are cases in which both of them are missing and therefore no
correct node is generated in this case. Therefore it is promising
to include nodes for other interpretations, especially in the low
and high mass range of the spectrum where fragmentation is
usually less complete.
While the longest antisymmetric path problem is NP-
complete for general directed graphs [13], there exist polyno-
mial algorithms for the special case where the non-interleaving
property is satisfied. The polynomial algorithm proposed by
Chen [14] uses dynamic programming to compute an op-
timal solution to the longest antisymmetric path with non-
interleaving forbidden pairs. In a second paper Lu and Chen
[15] extended this approach to compute suboptimal solutions
by constructing a so called matrix spectrum graph and ap-
plying depth-first search and a backtracking algorithm. In
contrast, the ILP formulation presented in the next section
does not depend on such a nested structure and corresponds
to the de novo sequencing problem for any desired set of ion
types.
B. Integer Linear Programming Formulation
Our algorithm is based on the following integer linear
programming (ILP) formulation [24], which is very similar
to the one Floudas and DiMaggio used for their tool PILOT
[11]. Our formulation models the problem by means of zero-
one variables for each edge. We put the score of each node on
all its outgoing directed edges. As the graph is acyclic, this is
a safe transformation.
max
∑
(vi,vk)∈ED
ci,kxi,k (1)
∑
(vs,vk)∈ED
xs,k = 1 (2)
∑
(vk,vt)∈ED
xk,t = 1 (3)
∑
(vi,vk)∈ED
xi,k −
∑
(vk,vj)∈ED
xk,j = 0 ∀k ∈ V \ {vs, vt} (4)
∑
vi∈e
∑
(vi,vk)∈ED
xi,k ≤ 1 ∀e ∈ EU (5)
xi,k ∈ {0, 1} (6)
We introduce a binary variable xi,k for every directed edge
(vi, vk) ∈ ED which has value one if edge (vi, vk) is part of
the path (active) and zero otherwise (inactive). The objective
4function (1) maximizes the summed score of all active directed
edges. For the two goalposts s and t, the two constraints (2)
and (3) assure that exactly one active edge leaves s and one
enters t. Together with the flow conservation constraints (4),
they establish a correspondence between feasible solutions of
the ILP and s-t paths in the graph. An optimal solution of the
ILP consisting of objective function (1) and constraints (2),
(3) and (4) corresponds to a longest s-t path, still possibly
symmetric and therefore infeasible for the de novo sequencing
problem. Therefore we add another constraint (5) that makes
sure that for each pair of contradicting nodes at most one
will be selected. The difference of our model to the one
proposed by Floudas and DiMaggio is twofold. First, we do
not introduce variables for nodes as they are not required. This
does not change the general structure of the formulation and
has no strong effect on the time required for solving. Second,
we do not formulate a constraint that prevents the exact mass
of the predicted sequence to deviate from the measured parent
mass by more than a certain threshold value (usually 2.5Da).
We argue that in our algorithm it is more promising to defer
this filtering to a later stage of the algorithm. Since we add
edges that correspond to pairs and triples of amino acids
which often represent several possible combinations of amino
acids, there is no exact mass which could be used in such a
constraint. Therefore we perform the filtering at a later stage
when we have created the candidate superset.
C. Applying Lagrangian Relaxation
While linear programming (LP) problems can be solved
in polynomial worst case time, adding integrality constraints
makes them generally NP-hard and the resulting integer lin-
ear programs (ILPs) require different algorithmic solution
approaches. One common method is to first solve the LP
relaxation and then investigate the obtained solution. If the
solution is fractional one has to resort to techniques like
branch-and-bound or branch-and-cut using upper and lower
bounds obtained from heuristics and from the relaxed solution.
We apply a different kind of relaxation method, Lagrangian
relaxation, which yields in many cases much more efficient
algorithms than those based on LP relaxations because it
can exploit structural knowledge of the problem. Lagrangian
relaxation is motivated by the experience that many hard
integer programming problems correspond to a significantly
easier problem that has been complicated by an additional
set of constraints. To obtain the efficiently computable La-
grangian problem, the complicating constraints are removed
and replaced by a penalty term in the objective function. The
relaxed problem obtained that way is called the Lagrangian
problem and can often be solved efficiently.
The Lagrangian relaxation of the de novo sequencing
ILP (1)-(6) is straightforward as it is very obvious that the
antisymmetry constraints form the class of hard constraints
that complicate the computationally easy problem of a longest
path search in a directed acyclic graph (DAG). We can solve
this relaxed problem by means of a simple standard algorithm,
which can be found in reference material [25]. To make
the Lagrangian relaxation more transparent we rewrite the
objective function in a way that the edge variables are grouped
by the undirected edges incident to their left end:
max
∑
e∈EU
∑
(vi,vk)∈ED,
vi∈e
ci,kxi,k .
Next we apply Lagrangian relaxation by dropping the anti-
symmetry constraint (5) and moving it to the objective function
to penalize its violation. This leads to the Lagrangian problem
Z(λ) = max
∑
e∈EU
∑
(vi,vk)∈ED,
vi∈e
(ci,k − λe)xi,k +
∑
e∈EU
λe (7)
∑
(vs,vk)∈ED
xs,k = 1
∑
(vk,vt)∈ED
xk,t = 1
∑
(vi,vk)∈ED
xi,k −
∑
(vk,vj)∈ED
xk,j = 0 ∀k ∈ V \ {vs, vt}
xi,k ∈ {0, 1}
The vector λ holds the Lagrangian multipliers, non-negative
real numbers that define the weight of the penalty term.
Lemma 1. The Lagrangian problem (7) can be solved in
linear time and space.
Proof: Solving the Lagrangian problem consist of the
following steps: First we simply subtract from each edge
weight ci,k the value λe, for all undirected edges e incident
to node vi. Then we apply the linear time O(|V | + |ED|)
longest path search algorithm for DAGs on the graph with the
modified edge weights. Finally we add the value of
∑
e∈EU
λe
to the score obtained from the longest path search algorithm.
Obviously each of the steps requires only linear time and
space.
By restricting the Lagrangian multipliers to non-negative
values one can easily show that the value of the solution of
the Lagrangian problem is an upper bound to the optimal value
of the original problem [26]. In order to obtain a tight bound,
the strategy is to find the values for the Lagrangian multipliers
that minimize Z(λ), which means solving the dual problem:
ZD = min
λ≥0
Z(λ) .
We apply the efficient iterative subgradient optimization al-
gorithm, computing sequences of multipliers λt where t =
0, 1, 2, . . . denotes the iteration. We start with λ0e = 0, for all
e ∈ EU and in each iteration t we compute the subgradients
Ste = 1−
∑
vi∈e
∑
(vi,vk)∈ED
xi,k, for all e ∈ EU and update
the Lagrangian multipliers according to formula:
λt+1e = max{0, λ
t
e − θ
tSte} . (8)
One crucial factor with a huge influence on the performance
is the step-size θ. The subgradient method converges to the
optimal solution ZD if the step-size satisfies the following
conditions [27]:
lim
k→∞
θk = 0 and lim
k→∞
k∑
i=1
θi = ∞ .
5A formula that is widely used for step-size computation
because it shows good performance in practice is given by
θt =
γt(Z(λt)− Z∗)∑
e∈EU
(Ste)
2
, (9)
where Z∗ is the value of the best solution to the original
problem that was computed yet and γt defines a decreasing
adaption parameter.
D. Suboptimal Solutions
A straightforward strategy to compute suboptimal solutions,
also implemented in PILOT [11], is to cut off previous
solutions by an additional constraint. A known drawback of
this approach is that solving time may increase dramatically
after generating a few suboptimal solutions. We suggest a
different strategy and overcome this problem by means of an
algorithm which, for a given number k, directly computes the
k longest paths. We use the algorithm by Yen [28] that was
originally designed to compute the k shortest paths without
cycles on general directed graphs.
Yen’s algorithm is a deviation algorithm based on the fact
that the i-th shortest path Pi, will coincide with every shorter
path Pi−1 . . . P1 up to some node until it deviates. The farthest
node from the source s with this property is called deviation
node d(Pi).
The strategy to find the i + 1-st shortest s-t path Pi+1
is, starting at d(Pi), to compute for each node vij of Pi the
shortest path to t, that deviates from Pi at node vij . Therefore a
shortest path from vij to t is computed which is not allowed to
use the edge (vij , vij+1). This shortest path from vij to t is then
concatenated with the prefix (vi1 . . . vij−1) of Pi to obtain the
shortest s-t path that deviates from Pi at node vij . This path is
added to a candidate set X . After the shortest deviating paths
of Pi have been computed, the shortest path in the candidate
set X corresponds to the i + 1-st shortest s-t path Pi+1 and
is removed from X .
Yen’s algorithm performs an additional trick to guarantee for
paths without cycles that we do not discuss here. For a more
detailed description of this algorithm and variants please refer
to reference material [28], [29].
Our problem differs in a few points from the original
problem solved by Yen’s algorithm, so it requires a few
adaptations. While Yen’s algorithm is designed for general
directed graphs that may contain cycles, we are working on
a DAG. This simplifies the problem as we do not have to
worry about cycles and can simply transform the shortest path
problem into a longest path problem. Note that the longest
path problem is NP-complete in graphs with cycles. A second
difference is that we have the additional condition to find
antisymmetric paths. Therefore every time the shortest path
algorithm is called in the Yen’s algorithm, we replace this by
solving the Lagrangian relaxation formulation for the longest
antisymmetric path search. The following theorem and its
proof capture the main algorithmic result of this paper.
Theorem 1. The combination of our Lagrangian relaxation-
based algorithm for antisymmetric paths and a modification of
Yen’s algorithm solves the problem of computing the k longest
antisymmetric paths in time O(kls(|E| + |V |)), where l is
the length of the longest path and s is the total number of
subgradient iterations.
Proof: In iteration i+1 of Yen’s algorithm the computed
path deviating from Pi at node vij must satisfy two conditions
in order to form an antisymmetric path in G.
1) There are no two nodes in the path from vij to t that are
in conflict.
2) None of the nodes in the computed path from vij to t is
in conflict with some node from the prefix of path Pi
up to node vij .
The first condition is satisfied by the Lagrangian relaxation
formulation itself, because if applied to the subgraph vij . . . t,
every feasible solution corresponds to an antisymmetric path
from node vij to t. To meet the second condition it is sufficient
to remove all nodes from the subgraph vij . . . t that are con-
nected via an undirected edge with some node of the prefix
s . . . vij of Pi before we compute the longest antisymmetric
path. This trick also simplifies the longest antisymmetric path
search for increasing j as the possibilities to generate an
infeasible solution are decreasing.
The complexity of Yen’s algorithm for computing the k-
longest paths in a DAG is O(k|V |(|E|+ |V |)). The first factor
|V | comes from the fact that, in a general graph, one path
can possibly contain all |V | nodes. In the case of peptide
sequencing, the length of a path equals the length of the
predicted peptide which usually does not exceed a length of 30
for typical experimental settings. In the longest antisymmetric
path version using Lagrangian relaxation, the O(|E| + |V |)
DAG longest path algorithm gets iteratively called during
subgradient optimization algorithm. Therefore the complexity
of our formulation for identification of a peptide containing l
amino acids is O(kls(|E|+ |V |)) with s being the number of
iterations during subgradient optimization.
Note that the value of s is possibly exponential if the
subgradient optimization does not converge and the complete
branch and bound tree has to be enumerated. Nevertheless,
in the results section we will show that for our peptide
sequencing formulation on average only very few iterations
are required which leads to a practically efficient algorithm.
E. Scoring Model
We use a probabilistic scoring based on a Bayesian network
similar to the scoring model of PepNovo. Bayesian networks
are directed acyclic graphs where nodes represent random
variables and the edges represent conditional dependencies
between variables. The variables in our model are the ion
types t ∈ T that are considered by our scoring model and the
possible values for each variable is the intensity. Therefore, as
a first step, we normalize the intensity of all peaks to discrete
values as defined by Dancˇı´k et al. [9] by using their rank as
intensity.
The usage of Bayesian networks for scoring nodes in
the spectrum graph is motivated by the observation that
fragmentation events are not independent. For example, the
probability of observing a strong b-ion is not independent of
the abundance and intensity of the complementary y-ion.
6Unlike for the PepNovo algorithm, where the structure of
the probabilistic network is predefined leading to a fixed set
of accounted conditional dependencies, we implemented a
flexible scoring scheme where the network topology can be
either defined by the user or it can be learned during the
training process automatically.
For inference and training of the Bayesian network we used
the Bayesian Network Classifiers in the machine learning suite
Weka [30]. Similar to PepNovo, we discretize the relative
position of a cleavage into several (default 3) equally sized
regions r to account for the different intensity distributions
in the center and terminal regions usually observed in CID
spectra. For each of the regions we train a Bayesian network
using some training set of tandem mass spectra with known
peptide identification. For each training spectrum we construct
the node set of the spectrum graph and select an equal number
of true positives (vertices representing a true PRM) and false
positives (vertices representing not representing PRM). For
each of the selected nodes we look for witnessing peaks at
their calculated positions and record their normalized intensity
to obtain the training vectors for the Bayesian network. Each
of the training vectors has one additional entry, the class label,
which is T for true positives and F for false positives. We
select only those ion types of the witness set for the network
training that appear in at least t percent of the true positive
samples of the training set where the threshold parameter t
can be defined by the user. For each of these selected types
we then add a node in the Bayesian network. One additional
node for the class is added. During the network training, the
structure (set of directed edges) of the network is learned and
once the structure is fixed the conditional probability tables are
learned from the training data. While the user can control a
huge range of possible options for the Weka Bayesian network
classifier training through our program, we set as the default
training algorithm the K2-HillClimber and the Bayesian metric
for local scoring [31]. For a user defined network topology the
first step is skipped and only the conditional probability tables
are computed.
Once the network is trained, we score a node v in the
spectrum graph by looking for peaks in the spectrum at the
calculated masses for the selected ion types to obtain the set of
intensity observations Iv. Using the trained Bayesian network
BN we then compute the log likelihood ratio as:
LLR(v) = log
Pr(Iv | BN, class = T)
Pr(Iv | BN, class = F)
, (10)
where Pr(Iv | BN, class = X ∈ {T, F}) is the probability
of observation Iv under model BN when the class variable is
set to X . In contrast to Bern and Datta who obtain their false
positive samples from perturbation of the correct PRM we only
take false positive PRM for which a node was created during
the spectrum graph construction. We chose that approach since
we want the Bayesian network to discriminate between correct
and false nodes in the spectrum graph. By just perturbing the
true PRM one will very likely generate false positive training
samples containing only zero intensity entries which will never
be the case for a node in the spectrum graph as it requires at
least one peak to be generated.
Additional to the Bayesian network we also use a simple
intensity rank score SR(v) as it is also used by INSPECT [1].
This score is the ratio between two probabilities, the proba-
bility that a peak with a certain intensity rank corresponds to
a certain ion type (e.g., a b-ion) and the the probability that a
randomly chosen peak was generated by that ion type. As these
values differ between different mass regions of a spectrum, we
split the spectrum into three equally spaced mass regions and
estimate the probabilities for each of them separately using the
same training data as for the Bayesian network. For example,
if we generate a node for a peak of rank 4, and this node
interprets the peak as a b-ion, then SR(v) is the log ratio
between the probability that a rank 4 peak is a b-ion and the
probability that any random peak is a b-ion.
The final score s(v) for each node v of the spectrum graph
is then computed as:
s(v) = LLR(v) + SR(v) (11)
Nodes having negative scores correspond to unreliable
PRMs and are removed from the graph in order to reduce
the size of the spectrum graph and speed up the candidate
generation process. Since our formulation is working with
edge weights, we move the node scores onto the edges,
such that each directed edge gets the score of its left node.
In the filtered spectrum graph we compute the predefined
number of suboptimal solutions, each corresponding to one
antisymmetric path. To account for missed cleavages we also
add edges corresponding to pairs and triples of amino acids to
the spectrum graph. For each of the generated candidates, in
a second step, we try to resolve the pairs and triples of amino
acids. Therefore we generate all possible combinations and
permutations of amino acids to generate a candidate superset.
The candidates in that superset are then re-scored by a refined
version of a shared peaks count where we reward abundant
witness peaks and penalize missing ones.
Given a candidate sequence we look for witnessing peaks
in the query spectrum and give a bonus if one was found or a
penalty if it is missing. Further we check whether the peak is
a primary isotopic peak, a secondary isotopic peak or a lone
peak. A peak is called a primary isotopic peak if we find a
child peak at offset 1 Da for a singly charged ion or 0.5 Da for
a doubly charged ion. Equivalently a peak is called a secondary
isotopic peak if it has a parent peak with offset -1 Da for a
singly charged ion or -0.5 Da for a doubly charged ion. If a
peak is neither primary isotopic nor secondary isotopic then
it is a lone peak. If a witnessing peak is a primary peak we
add another bonus to the score while we charge a penalty if it
is a secondary peak. While the reward and penalty score are
actually user parameters we will offer a generic algorithm to
estimate reasonable values in future versions. The candidates
are then re-ranked according to this score and the predefined
number of candidates is returned.
III. RESULTS
In this section we present and discuss our computational
results. We compared ANTILOPE with state-of-the-art alter-
native peptide identification software with respect to running
time and quality.
7A. Efficiency
The major contribution of this work is the new algorithmic
approach based on Lagrangian relaxation. We will first give
a thorough analysis of the performance and compare it to
the ILP formulation (1)-(6). Like implemented in PILOT, we
generate the suboptimal solutions by introducing additional
constraints that cut off previous solutions. We implemented
our algorithm in C++ and use the OpenMS [23] library that
offers convenient data structures and algorithms to handle and
manipulate spectral data. For the ILP formulation we use the
commercial CPLEX [32] solver software (version 9.0), which
is in general the fastest solver available. We were not able
to directly compare to PILOT because the software is not
available upon request. In Fig. 4 we compare the running times
of the ILP and our Lagrangian relaxation formulation on a set
of 100 tandem mass spectra from the ISB dataset [33]. In this
comparison we only consider the time required to generate
the set of candidate sequences and ignore the preprocessing
of the spectrum and the spectrum graph generation as these
steps are independent of the applied algorithm. We compared
the running time required to generate the top scoring 20, 30
and 50 candidates for each spectrum. The figure shows that
our approach significantly outperforms the ILP formulation
on all instances and the performance gain increases with the
number of candidates to be generated. Our algorithm is on
average ≈ 9 times faster for the best 20 candidates, for 30 and
50 candidates the average advantage increases to a factor of
≈ 12 and ≈ 18. While the run time for of the ILP formulation
for the top 50 candidates was usually above 2 seconds, the
Lagrangian relaxation formulation requires on average only a
few tenths of a second.
In a closer analysis we investigated the convergence behav-
ior of our Lagrangian relaxation formulation. It reveals that
for each Lagrange problem solved during the path ranking
algorithm only very few iterations of the subgradient opti-
mization are required. The path ranking algorithm maintains a
list of previously detected candidate paths together with their
scores. Since the score Z(λ) of the Lagrange problem is an
upper bound to the score ZIP of the best possible feasible
solution, subgradient optimization can be aborted as soon as
Z(λ) falls below the lowest score in the candidate list. If the
Lagrangian relaxation does not converge and cannot be aborted
after 100 iterations we apply a branching step. We use the best
infeasible path found during the subgradient optimization and
arbitrarily choose one node vb involved in a conflict. Then we
generate two subproblems, one forcing vb to be in the path
and one forbidding vb to be selected. We found that only for a
very small fraction of the Lagrange problems a branching step
had to be performed, and the depth of branch-and-bound trees
never exceeded a value of three. It is necessary to mention
that the performance strongly depends on the scoring function
used, since a good scoring function will not generate many
high scoring nodes for the same peak and only the correct
one should receive a significantly high score. Therefore a
good scoring function does not only affect the identification
performance but also affects the complexity of the candidate
generation.
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Fig. 4. Running time comparison between Lagrangian relaxation and
ILP formulation for computation of 20, 30, and 50 suboptimal solutions
of 100 benchmark spectra. Box-and-whisker plots display median, quar-
tiles, and extrema of the distribution of relative performance gains rpg =
run-time(ILP)/run-time(Lagrange). ANTILOPE outperforms the CPLEX-based
method for all spectra and all numbers of suboptimal solutions. The advantage
increases with the number of suboptimal solutions. The considered spectrum
graphs contained between 80 and 200 nodes.
B. Sequencing Performance
We compared the performance of ANTILOPE to four
non-commercial de novo sequencing tools, LutefiskXP,
NovoHMM, PILOT1, PepNovo and the commercial software
PEAKS2. We used two measures, accuracy and recall, to
assess their performance. Accuracy denotes the fraction of cor-
rectly predicted amino acid residues compared to all predicted
residues. Recall is the fraction of correctly predicted residues
compared to the total number of residues of the correct
peptide sequences. When looking at suboptimal solutions for
each algorithm we looked for the prediction with the highest
recall and reported the values of this prediction for recall
and precision. In case of multiple predictions with the same
recall value we report the values for the one with the highest
precision among them. As benchmark set, we chose tandem
mass spectra from the ISB dataset [33] that were generated
by an ESI-ion trap mass spectrometer by Thermo Finnigan
and spectra from the open proteomics database. This set of
reliably annotated spectra from tryptic peptides has already
been used for training of PepNovo and NovoHMM. We created
a training set of 1214 spectra from doubly charged precursor
ions of unique peptides to train the scoring model. During the
Bayesian network training for each of the 3 mass sectors, only
the ion types that had a peak in at least 20% of the true positive
training samples are selected for the corresponding Bayesian
network. The topologies of the Bayesian networks together
1As PILOT was not available, the identifications for the test data were
generated by the authors of PILOT.
2We used the PEAKS Online 2.0 web interface.
8Fig. 5. Benchmark. Comparison of accuracy and recall of ANTILOPE with NovoHMM, PepNovo, PILOT, PEAKS and LutefiskXP. We compare the accuracy
and recall of the best prediction among the top 1, 3, 5 and 10 ranked candidates returned by each tool. As the best prediction we consider the one with the
best recall among the candidates. Since NovoHMM generates only one candidate per spectrum it appears only in the first plot. Discussion in text.
with a brief discussion can be found in the supplementary ma-
terial. The parameters to score the peptide spectrum matches
for the candidate sequences in the superset were chosen as
follows: For an abundant b- or y-ion we awarded the score
PSMb = PSMy = 1, doubly charged b- or y-ions scored
0.5, a-ions 0.3 and all neutral losses were awarded a score of
0.2. Isotopic peaks for some type t were awarded a score of
PSMt ·0.2. If some peak was missing the penalty of PSMt ·0.5
was subtracted from the score. When a peak was classified
as a secondary peak its score is reduced to PSMt · 0.8. The
score for some peak is then weighted with the relative m/z
distance between the expected and the observed m/z value
using a linear function.
The test set consists of 200 spectra of peptides (peptides
in training and test dataset disjunct) with a molecular mass
of at most 1600Da and an average peptide length of 10
residues. We score a predicted amino acid as correct, if its
predicted starting mass position does not deviate by more than
2.5Da from the correct starting mass position. Further, in our
evaluation we do not discriminate between the amino acids
Q/K and and I/L since their masses cannot be distinguished.
To compare the tools we do not only look at the top hit,
but we also look at the accuracy and recall for the best hit
in the top 3, 5 and 10 candidates. The results are presented
in Fig. 5. Since NovoHMM only generates one candidate per
spectrum it appears only in the first plot. Looking only at the
top hit, the recall of ANTILOPE (≈ 73.4%) is only marginally
lower than of PEAKS (≈ 73.7%) but slightly better than that
of PILOT (≈ 71.5%), NovoHMM (≈ 70.2%) and PepNovo
(≈ 69.4%). The recall of LutefiskXP (≈ 60.6%) is much lower
than for all other tools. Since ANTILOPE and NovoHMM both
compute complete sequences, they have almost equal values
for accuracy and recall, while for LutefiskXP and PepNovo
these values differ as they allow for gaps in their predicted
sequences. If we go over from the top hit to the best 3, 5 and
10 candidates, we observe that in terms of recall, ANTILOPE is
always very close to PepNovo and PEAKS (equal for the top
3, 2.5% advantage of PepNovo and PEAKS for the top 10)
and always approximately 4% better than PILOT. In terms of
accuracy PepNovo (≈ 92%) has a better performance than
ANTILOPE, PEAKS and PILOT since it allows for partial
peptide predictions. The accuracy of LutefiskXP is slightly
better than for ANTILOPE and PILOT but this accuracy is
achieved at a much lower recall which is between 12%
and 14% lower in all four cases. The four tools ANTILOPE,
LutefiskXP, NovoHMM and PepNovo are comparable in terms
of run time which is usually between 0.5 and 1.5 seconds
per spectrum. The running time of PILOT as reported by
the authors was on average around 9 seconds per spectrum.
We cannot directly estimate the runtime of PEAKS since the
identification is performed via a web interface.
IV. CONCLUSION
We proposed a new algorithmic approach to solve the
longest antisymmetric path problem by means of Lagrangian
relaxation, combined with a polynomial algorithm for subopti-
mal solutions. Using this approach the algorithm is flexible and
not restricted to the nested structure of the spectrum graph and
solves this problem much faster than an LP relaxation-based
method for the same formulation. Therefore, for our tool AN-
TILOPE, the candidate generation is no longer the bottleneck
as the most time consuming step is the re-ranking phase since
the number of possible candidates can easily explode if several
double and triple amino acid edges are selected. In terms of
sequencing performance, ANTILOPE is already competitive to
available state-of-the-art programs PepNovo and PEAKS while
it outperforms LutefiskXP and NovoHMM especially if we
also consider suboptimal solutions. For long peptides PepNovo
still has a small advantage, which is mostly due to the fact
9that the current version of ANTILOPE produces only complete
annotations without gaps.
Actually we only generated two nodes for each peak, one
for a b- and one for a y-ion. Generating nodes for all ion
types decreased the performance as this always lead to some
high scoring, but false nodes and thus to wrong interpretations.
Nevertheless we are sure that generating more nodes can
lead to better identifications in combination with a refined
scoring scheme. The algorithmic framework is flexible enough
to work with mass spectra generated by different kind of
mass spectrometers. So the user can define for which ion
types a node shall be generated. This can lead to improved
identification performance for different datasets. Combined
with a scoring function trained on a representative set of
spectra, the ability of our algorithm to directly model multiply
charged ions can lead to an improvement over the other
algorithms when analyzing tandem mass spectra obtained from
higher charged precursor ions.
For the future we plan to improve our algorithm in several
directions. We will include support for identification of pep-
tides containing post-translational modifications. Further we
want to support combinations of complementary fragmentation
techniques like CID together with electron transfer dissocia-
tion (ETD) or CID with electron capture dissociation (ECD),
which can improve the identification [22], [34]. In these
applications the flexibility of our formulation may become a
major advantage over the other programs.
To improve the performance for spectra of longer peptides
we will extend ANTILOPE in a way that it can produce
partial predictions allowing for gaps at the terminals. This,
together with a machine learning strategy for the re-scoring
like the rank-boosting algorithm used by PepNovo, should
lead to a further improvement. ANTILOPE is freely available
as part upcoming releases of the open source proteomics
library OpenMS [23] allowing for convenient integration into
experimental workflows.
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